mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
0.026 |
0.9 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
mRNA |
FGIN-1-27 |
CTRPv2 |
pan-cancer |
AAC |
0.006 |
0.9 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |